探索瘤微环境在扩散性内在庞丁质瘤:免疫学见解和治疗挑战
Bieke Van den Ende1, Matteo Riva1,2, Frederik De Smet3
1Department of Oncology, KU Leuven, Leuven, Belgium.
Journal for immunotherapy of cancer
|June 13, 2025
概括
扩散内在庞丁质瘤 (DIPG) 是一种罕见的儿科脑瘤. 了解其免疫微环境对于开发新的免疫疗法以改善患者存活率至关重要.
科学领域:
- 儿科瘤学 儿科瘤学
- 神经瘤学神经瘤学
- 癌症免疫学 癌症免疫学
背景情况:
- 扩散内在庞丁质瘤 (DIPG) 是一种罕见的,侵袭性的儿科脑瘤,起源于庞丁.
- 手术切除是不可行的,目前的治疗方法,如辐射提供有限的生存益处.
- 人们对瘤的免疫微环境知之甚少,这对有效的免疫疗法开发构成了重大障碍.
研究的目的:
- 提供对目前对DIPG免疫格局的理解的全面审查.
- 为了确定DIPG免疫学的现有研究缺口.
- 建议未来的研究方向,以改善DIPG治疗结果.
主要方法:
- 关于DIPG免疫学的最新研究的文献综述.
- 对瘤免疫微环境特征的分析.
- 在DIPG中识别免疫学子组.
主要成果:
- DIPG瘤通常被认为是"免疫冷"的,免疫细胞透率最小.
- 最近的研究表明,DIPG中存在复杂而异质的免疫场景.
- 在DIPG中已经确定了不同的免疫学子组.
结论:
- 对DIPG免疫微环境进行进一步的研究是必不可少的.
- 了解DIPG的免疫异质性可能会解锁新的治疗策略.
- 准免疫格局有望改善DIPG患者的治疗结果.
相关概念视频
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Tumor Immunotherapy
601
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
601


